test

Steve R. Bailey

@Frazier Life Sciences Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$2.495BTotal holdings53
Assets growth rate16.72%Assets growth rate (2-Q avg)3.46%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 53 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.495B in assets, with a quarterly growth rate of 16.72% and a 2-quarter average growth rate of 3.46%. The portfolio is managed by Steve R. Bailey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ALLOAllogene Therapeutics Inc
Recent Activity
0.33%
$8.03M
2.868M shares@ $2.8 avg price
PBYIPuma Biotechnology Inc
Recent Activity
0.32%
$7.81M
3.063M shares@ $2.56 avg price
ADVMAdverum Biotechnologies Inc
Recent Activity
0.31%
$7.506M
1.069M shares@ $7.03 avg price
ETNB89bio Inc
Recent Activity
0.3%
$7.4M
1M shares@ $7.4 avg price
ACADAcadia Pharmaceuticals Inc
Recent Activity
0.29%
$7.234M
470,338 shares@ $15.38 avg price
ARVNArvinas Inc
Recent Activity
0.29%
$7.028M
285,331 shares@ $24.64 avg price
PEPGPepgen Inc
Recent Activity
Decreased -53.24%
0.25%
$6.008M
702,694 shares@ $8.56 avg price
ELEVElevation Oncology Inc
Recent Activity
Increased 102.59%
0.15%
$3.596M
5.994M shares@ $0.6 avg price
NAMSWNewamsterdam Pharma Company
Recent Activity
0.15%
$3.502M
500,333 shares@ $7.0 avg price
IMCRImmunocore Hldgs Plc
Recent Activity
0.14%
$3.386M
108,762 shares@ $31.13 avg price